These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22035757)

  • 1. Management options for follicular lymphoma: observe; R-CHOP; B-R; others?
    McLaughlin P
    Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S91-5. PubMed ID: 22035757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival.
    Turturro F
    Expert Rev Anticancer Ther; 2007 Jul; 7(7):959-65. PubMed ID: 17627454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel treatment strategies in follicular lymphoma.
    Buske C; Dreyling H; Unterhalt M; Hiddemann W
    Ann Hematol; 2004; 83 Suppl 1():S72. PubMed ID: 15124680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current immunochemotherapy strategies in follicular lymphoma.
    Giné E; Gutiérrez-García G; López-Guillermo A
    Adv Ther; 2010 Oct; 27(10):704-13. PubMed ID: 20820973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of follicular lymphoma].
    Buske C; Unterhalt M; Hiddeman W
    Internist (Berl); 2007 Apr; 48(4):372-81. PubMed ID: 17287964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and perspective of antibody therapy in follicular lymphoma.
    Buske C; Weigert O; Dreyling M; Unterhalt M; Hiddemann W
    Haematologica; 2006 Jan; 91(1):104-12. PubMed ID: 16434378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
    Seiler T; Hiddemann W; Dreyling M
    Immunotherapy; 2009 Nov; 1(6):1015-24. PubMed ID: 20635916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of follicular lymphoma: current status.
    Tilly H; Zelenetz A
    Leuk Lymphoma; 2008; 49 Suppl 1():7-17. PubMed ID: 18821428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
    Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R
    Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
    Cohen Y; Solal-Céligny P; Polliack A
    Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.
    Buchegger F; Press OW; Delaloye AB; Ketterer N
    Oncologist; 2008 Jun; 13(6):657-67. PubMed ID: 18586921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radioimmunotherapy of follicular lymphoma: a step towards cure?].
    Ketterer N; Bischof Delaloye A; Helg C; Luthi F; Buchegger F
    Bull Cancer; 2007 Sep; 94(9):799-806. PubMed ID: 17878100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
    Zinzani PL; Pulsoni A; Perrotti A; Soverini S; Zaja F; De Renzo A; Storti S; Lauta VM; Guardigni L; Gentilini P; Tucci A; Molinari AL; Gobbi M; Falini B; Fattori PP; Ciccone F; Alinari L; Martelli M; Pileri S; Tura S; Baccarani M
    J Clin Oncol; 2004 Jul; 22(13):2654-61. PubMed ID: 15159414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular lymphoma: emerging therapeutic strategies.
    Kenkre VP; Kahl BS
    Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies?
    Illidge T; Chan C
    Leuk Lymphoma; 2008 Jul; 49(7):1263-73. PubMed ID: 18604715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolent lymphomas: current and emerging treatment approaches.
    Maloney D; Kahl BS; Dreyling M
    Clin Adv Hematol Oncol; 2006 Sep; 4(9 Suppl 20):1-10; quiz 11-2. PubMed ID: 17139243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.
    Derenzini E; Stefoni V; Maglie R; Casadei B; Pellegrini C; Broccoli A; Stefani G; Fanti S; Motta MR; Narducci R; Argnani L; Zinzani PL
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1695-701. PubMed ID: 24055654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab maintenance versus retreatment in follicular lymphoma.
    Palla AR; Hamadani M
    Hematol Oncol; 2013 Dec; 31(4):171-8. PubMed ID: 23044794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing newly diagnosed follicular lymphoma: state of the art and future perspectives.
    Li ZM; Ghielmini M; Moccia AA
    Expert Rev Anticancer Ther; 2013 Mar; 13(3):313-25. PubMed ID: 23477518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.